Bank of Montreal’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-32,756
Closed -$918K 4635
2022
Q1
$918K Buy
+32,756
New +$898K ﹤0.01% 2408
2021
Q2
Sell
-4,423
Closed -$89K 5381
2021
Q1
$89K Sell
4,423
-4,093
-48% -$94.5K ﹤0.01% 3447
2020
Q4
$189K Buy
8,516
+7,009
+465% +$133K ﹤0.01% 3247
2020
Q3
$26K Sell
1,507
-1,085
-42% -$19.7K ﹤0.01% 3723
2020
Q2
$47K Buy
+2,592
New +$30.2K ﹤0.01% 3477
2020
Q1
Sell
-3,838
Closed -$96K 4951
2019
Q4
$96K Buy
3,838
+1,144
+42% +$23.2K ﹤0.01% 3520
2019
Q3
$46K Buy
2,694
+118
+5% +$2.15K ﹤0.01% 3665
2019
Q2
$59K Sell
2,576
-51,690
-95% -$1.39M ﹤0.01% 3613
2019
Q1
$1.75M Sell
54,266
-2,843
-5% -$88K ﹤0.01% 1755
2018
Q4
$1.61M Sell
57,109
-7,732
-12% -$226K ﹤0.01% 1648
2018
Q3
$1.86M Buy
64,841
+19,860
+44% +$597K ﹤0.01% 1704
2018
Q2
$1.69M Buy
44,981
+40,685
+947% +$1.6M ﹤0.01% 1732
2018
Q1
$169K Buy
4,296
+114
+3% +$4.16K ﹤0.01% 2709
2017
Q4
$135K Buy
+4,182
New +$125K ﹤0.01% 2870
2017
Q1
Sell
-5,044
Closed -$52K 4265
2016
Q4
$52K Buy
5,044
+1,002
+25% +$13K ﹤0.01% 3101
2016
Q3
$64K Buy
+4,042
New +$60.9K ﹤0.01% 2967
2016
Q2
Sell
-266
Closed -$5K 4401
2016
Q1
$5K Buy
+266
New +$4.82K ﹤0.01% 3808

Bank of Montreal's XENT Position: Q2 2022 in Review

Bank of Montreal sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 32,756 shares — an estimated $918K sold.

Bank of Montreal first reported a position in XENT in Q1 2016 and held it in 17 quarters. The position peaked at $1.86M in Q3 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Bank of Montreal reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 32,756 Intersect ENT, Inc shares in Q2 2022, an estimated $918K.
  • Bank of Montreal first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 17 quarters.
  • Bank of Montreal's Intersect ENT, Inc position peaked at $1.86M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.